Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HDAC1 | Q13547 | 6/20 | 0.53 |
| ▸ | RAB9A | P51151 | 1/20 | 0.53 |
| ▸ | LMNA | P02545 | 1/20 | 0.53 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.52 |
| ▸ | MAPT | P10636 | 1/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.50 |
| ▸ | NAMPT | P43490 | 2/20 | 0.49 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.48 |
| ▸ | MEN1 | O00255 | 1/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.47 |
| ▸ | ICOSLG | O75144 | 1/20 | 0.46 |
| ▸ | ICOS | Q9Y6W8 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3957848 | 0.92 | HDAC1 (0.58) | HDAC1RAB9ASMN1; SMN2MAPTALDH1A1 | |
| SCHEMBL3957764 | 0.88 | HDAC1 (0.56) | HDAC1RAB9ALMNASMN1; SMN2MAPT | |
| SCHEMBL3879832 | 0.85 | KDR (0.48) | HDAC1RAB9ASMN1; SMN2MAPTALDH1A1 | |
| SCHEMBL3959300 | 0.84 | SMN1; SMN2 (0.60) | HDAC1RAB9ALMNASMN1; SMN2MAPT | |
| SCHEMBL3955981 | 0.83 | ALDH1A1 (0.51) | HDAC1RAB9ASMN1; SMN2MAPTALDH1A1 | |
| SCHEMBL3957596 | 0.83 | HDAC1 (0.49) | HDAC1RAB9ASMN1; SMN2MAPTALDH1A1 | |
| SCHEMBL3960045 | 0.81 | HDAC1 (0.53) | HDAC1RAB9ALMNASMN1; SMN2MAPT | |
| SCHEMBL3954529 | 0.81 | MAPK1 (0.56) | HDAC1RAB9ASMN1; SMN2MAPTALDH1A1 | |
| SCHEMBL3957756 | 0.81 | NPC1 (0.50) | HDAC1RAB9ASMN1; SMN2MAPTALDH1A1 | |
| SCHEMBL3954526 | 0.81 | MEN1 (0.49) | HDAC1RAB9ALMNASMN1; SMN2MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2079525-A1 | CALCIUM RECEPTOR MODULATING AGENTS | Amgen Inc. (US) | 2009-07-22 | — | — | EP | claimed |
| WO-2008057282-A1 | CALCIUM RECEPTOR MODULATING AGENTS | AMGEN INC. (US) | 2008-05-15 | — | — | WO | claimed |
| EP-2079525-A1 | CALCIUM RECEPTOR MODULATING AGENTS | Amgen Inc. (US) | 2009-07-22 | — | — | EP | disclosed |
| WO-2008057282-A1 | CALCIUM RECEPTOR MODULATING AGENTS | AMGEN INC. (US) | 2008-05-15 | — | — | WO | disclosed |